Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
For Stock Market Bulls, There's Potential Downside to Economic Opening - BNN Bloomberg
Teva Stock Climbs as Earnings Hint at Turnaround | Barron's
HSBC downgrades Teva on uncertainty surrounding DOJ's reported generic drug investigation
テバ：株価急落－４～６月は18％減収、北米ジェネリック販売低迷 - Bloomberg
Teva mulling bid for Mylan – Bloomberg - Globes
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva's New CEO Schultz Says Forget About Recovery This Year
Teva Analysts Say Migraine Drug Approval Gives Needed Relief
Teva Has No Plans for Covid Vaccine Research, CEO Kare Schultz Says: Video - Bloomberg
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva shares up on report of 10,000 job cuts
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
27点のPharmaceutical Drug Roundup Inside A Pharmacyのストックフォト - Getty Images
Israel's Teva in talks to set up China venture with Guangzhou Pharma
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Lately, When Analysts Say Buy, It Has Paid to Do What They Say - BNN Bloomberg
Teva Pharmaceutical (TEVA) Stock Rating Cut at HSBC - TheStreet
